Your browser doesn't support javascript.
loading
Correction to: Preclinical development of ZED8, an 89Zr immuno­PET reagent for monitoring tumor CD8 status in patients undergoing cancer immunotherapy.
Ogasawara, Annie; Kiefer, James R; Gill, Herman; Chiang, Eugene; Sriraman, Shravan; Ferl, Gregory Z; Ziai, James; Bohorquez, Sandra Sanabria; Guelman, Sebastian; Wang, Xiangdan; Yang, Jihong; Phan, Minh Michael; Nguyen, Van; Chung, Shan; Yu, Christine; Tinianow, Jeff; Waaijer, Stijn Jan Hein; De Crespigny, Alex; Marik, Jan; Boswell, C Andrew; Zabka, Tanja; Staflin, Karin; Williams, Simon-Peter.
Affiliation
  • Ogasawara A; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Kiefer JR; Department of Structural Biology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Gill H; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Chiang E; Department of Cancer Immunology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Sriraman S; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Ferl GZ; Preclinical and Translational Pharmacokinetics, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Ziai J; Research Pathology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Bohorquez SS; Oncology Exploratory Clinical Development, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Guelman S; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Wang X; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Yang J; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Phan MM; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Nguyen V; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Chung S; BioAnalytical Sciences, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Yu C; Department of Structural Biology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Tinianow J; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Waaijer SJH; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • De Crespigny A; Oncology Exploratory Clinical Development, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Marik J; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Boswell CA; Preclinical and Translational Pharmacokinetics, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Zabka T; Safety Assessment Pathology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Staflin K; Safety Assessment Toxicology, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA.
  • Williams SP; Department of Biomedical Imaging, Genentech, Inc, 1 DNA Way, South San Francisco, CA, 94080, USA. williams.simon@gene.com.
Eur J Nucl Med Mol Imaging ; 50(2): 631, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36427067
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2023 Document type: Article Affiliation country: